Barenkam S J, St Geme J W
Department of Pediatrics, St. Louis University School of Medicine, Missouri, USA.
Infect Immun. 1996 Aug;64(8):3032-7. doi: 10.1128/iai.64.8.3032-3037.1996.
We previously reported that two surface-exposed high-molecular-weight proteins, HMW1 and HMW2, expressed by a prototypic strain of nontypeable Haemophilus influenzae (NTHI) mediate attachment to human epithelial cells. These proteins are members of a family of highly immunogenic proteins common to most nontypeable Haemophilus strains. We also reported that immunization with an HMW1-HMW2 mixture modified the course of disease in an animal model of otitis media, suggesting the potential usefulness of these proteins as NTHI vaccine components. Identification of surface-accessible B-cell epitopes could be important to efforts to develop recombinant or synthetic peptide vaccines based upon these high-molecular-weight proteins. Thus, the purpose of the present study was to identify surface-accessible epitopes on the HMW1 and HMW2 proteins by using monoclonal antibodies (MAbs) and to determine the prevalence of these epitopes among the high-molecular-weight proteins expressed by heterologous nontypeable Haemophilus strains. MAbs were generated by immunizing mice with high-molecular-weight proteins purified from prototype strains and were screened by immunoelectron microscopy (IEM) for the ability to recognize surface epitopes. Two MAbs, designated AD6 and 10C5, that recognized surface epitopes by IEM were recovered. In order to map the epitopes recognized by these two MAbs, we constructed a set of HMW1 and HMW2 recombinant fusion proteins using the pGEMEX vectors and examined the reactivity of the MAbs with these fusion proteins. MAb AD6 recognized an epitope in both HMW1 and HMW2 which mapped to the last 75 amino acids at the carboxy termini of the two proteins. When examined for reactivity with heterologous strains, MAb AD6 recognized high-molecular-weight proteins in 75% of 125 unrelated nontypeable Haemophilus strains and, in addition, reacted with three of three such strains when examined by IEM. MAb 10C5 recognized an epitope that mapped to a 155-amino-acid segment near the carboxy terminus of HMW1. This epitope was adjacent to but distinct from the AD6 epitope and was absent from HMW2. The 10C5 epitope was expressed by 40% of the AD6 reactive strains. Identification of shared surface-exposed epitopes on the high-molecular-weight adhesion proteins suggests the possibility of developing recombinant or synthetic peptide-based vaccines protective against disease caused by the majority of NTHI strains.
我们之前报道过,不可分型流感嗜血杆菌(NTHI)的原型菌株表达的两种表面暴露的高分子量蛋白HMW1和HMW2介导其与人上皮细胞的附着。这些蛋白是大多数不可分型嗜血杆菌菌株共有的高度免疫原性蛋白家族的成员。我们还报道过,用HMW1 - HMW2混合物免疫可改变中耳炎动物模型中的病程,这表明这些蛋白作为NTHI疫苗成分具有潜在用途。鉴定表面可及的B细胞表位对于基于这些高分子量蛋白开发重组或合成肽疫苗的努力可能很重要。因此,本研究的目的是利用单克隆抗体(MAb)鉴定HMW1和HMW2蛋白上的表面可及表位,并确定这些表位在异源不可分型嗜血杆菌菌株表达的高分子量蛋白中的普遍性。通过用从原型菌株纯化的高分子量蛋白免疫小鼠产生单克隆抗体,并通过免疫电子显微镜(IEM)筛选其识别表面表位的能力。回收了两种通过IEM识别表面表位的单克隆抗体,命名为AD6和10C5。为了定位这两种单克隆抗体识别的表位,我们使用pGEMEX载体构建了一组HMW1和HMW2重组融合蛋白,并检测了单克隆抗体与这些融合蛋白的反应性。单克隆抗体AD6在HMW1和HMW2中都识别一个表位,该表位位于这两种蛋白羧基末端的最后75个氨基酸处。当检测其与异源菌株的反应性时,单克隆抗体AD6在125株无关的不可分型嗜血杆菌菌株中的75%中识别出高分子量蛋白,此外,通过IEM检测时,它与三株此类菌株中的三株都发生了反应。单克隆抗体10C5识别一个表位,该表位位于HMW1羧基末端附近的一个155个氨基酸的片段上。这个表位与AD6表位相邻但不同,且在HMW2中不存在。10C5表位在40%的AD6反应性菌株中表达。鉴定高分子量黏附蛋白上共享的表面暴露表位提示了开发针对大多数NTHI菌株引起的疾病具有保护作用的基于重组或合成肽的疫苗的可能性。